Sivextro Injection, Powder, Lyophilized, For Solution
Product Images NDC 67919-040

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Sivextro (NDC 67919-040). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Merck Sharp & Dohme Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Sivextro 01)

FDA Label Image

Principal Display Panel (200 mg Tablet Blister Pack Carton)

Principal Display Panel (200 mg Tablet Blister Pack Carton)
This appears to be a combination of medical and numerical data, likely related to a prescription drug called Sivextro. The text lists the drug's name and dosage, as well as a product code and details on how many tablets are included. There are also various numbers and codes included, but it's unclear what they represent without additional context.*
FDA Label Image

Principal Display Panel (200 mg Vial Carton)

Principal Display Panel (200 mg Vial Carton)
This is a pharmaceutical product named Sivextro, containing tedizolid phosphate as an active ingredient. It's available in a package of 10 single-use vials. The usual dosage is 200 mg once a day. The product is stored at a controlled room temperature of 20-25°C but can be excursed to 15-30°C. The pack contains a package insert having dosing and administration information. It is intended for intravenous infusion with Ringer's solution after reconstitution. The parenteral drug products should be visually inspected for particulate matter before administration.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.